Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sarissa Biomedical is a specialized biotechnology company that develops and manufactures high-performance microelectrode biosensors for the real-time detection of neurochemicals. Spun out from the University of Warwick, the company's core technology enables the measurement of purines such as adenosine and ATP, as well as other neurotransmitters like glutamate and acetylcholine. Their products are primarily used in neuroscientific research to study brain function, stroke, and trauma. Sarissa is also advancing clinical applications for its sensor technology, aiming to provide rapid point-of-care diagnostics for conditions like stroke and cardiac ischemia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sarissa.